BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10467321)

  • 1. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.
    Rosenzwajg M; Fery N; Bons V; Damaj G; Gluckman E; Gluckman J
    Bone Marrow Transplant; 1999 Aug; 24(4):351-4. PubMed ID: 10467321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.
    Gentile G; Capobianchi A; Volpi A; Palù G; Pica F; Calistri A; Biasolo MA; Martino P
    J Natl Cancer Inst; 2005 Jul; 97(13):1008-11. PubMed ID: 15998954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation prevalence of human herpes virus 8 antibodies in kidney donors and recipients in Athens, Greece.
    Panayiotakopoulos GD; Papaconstantinou I; Mavroyianni D; Kostakis A; Kordossis T
    Transplant Proc; 2005 Dec; 37(10):4180-2. PubMed ID: 16387072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
    J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
    Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence and risk factors of human herpes virus 8 infection in Central-East Tunisia].
    Hannachi N; Ben Fredj N; Samoud S; Ferjani A; Khlif A; Boughammoura L; Soussi S; Aouni M; Skouri H; Boukadida J
    Pathol Biol (Paris); 2012 Oct; 60(5):282-6. PubMed ID: 22115818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma.
    Dupuy A; Schulz T; Chevret S; Agbalika F; Pellet C; Janier M; Dupin N; Vérola O; Calvo F; Lebbé C
    Br J Dermatol; 2009 Mar; 160(3):540-5. PubMed ID: 19077076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
    Marcelin AG; Roque-Afonso AM; Hurtova M; Dupin N; Tulliez M; Sebagh M; Arkoub ZA; Guettier C; Samuel D; Calvez V; Dussaix E
    Liver Transpl; 2004 Feb; 10(2):295-300. PubMed ID: 14762870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.
    Bacigalupo A; Oneto R; Bruno B; Soracco M; Lamparelli T; Gualandi F; Occhini D; Raiola A; Mordini N; Berisso G; Bregante S; Dini G; Lombardi A; Lint MV; Brand R
    Bone Marrow Transplant; 1999 Sep; 24(6):653-9. PubMed ID: 10490732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children.
    Bogdanovic G; Priftakis P; Taemmeraes B; Gustafsson A; Flaegstad T; Winiarski J; Dalianis T
    Pediatr Transplant; 1998 Nov; 2(4):288-93. PubMed ID: 10084731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
    Yoshikawa T; Asano Y; Ihira M; Suzuki K; Ohashi M; Suga S; Kudo K; Horibe K; Kojima S; Kato K; Matsuyama T; Nishiyama Y
    J Infect Dis; 2002 Apr; 185(7):847-53. PubMed ID: 11920307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.